Speaker - Oswaldo A Lozoya, PhD, Genomics Staff Scientist - TSAIL, IQVIA Laboratories
As part of the Machine Learning and Single Cell Genomics in Public Health session, Oswaldo presents insights, experiences, and strategies to improve clinical relevance of biomarker (re)discovery science on the heels of the Era of Big Data and High-Resolution Biology.
Related Insights
IQVIA Laboratories Central Laboratory Services
Central laboratory solutions supporting clinical trials around the world
MASH and Liver Disease Capabilities
Anatomic Pathology brochure
Comprehensive in-house end-to-end anatomic pathology and adjunct molecular services
Flow Cytometry Services
Leader in flow cytometry services for clinical trials
A Global Network to Empower Leaner Oncology Clinical Trials: Unlocking the Potential of Local Genomic Biomarker Testing in Europe
Translational Science and Innovation Laboratory (TSAIL)
Translational biomarker solutions to accelerate the adoption of assays into clinical trials though new technology evaluation and early biomarker discovery
Alzheimer’s Disease Clinical Trials
Innovative laboratory solutions to accelerate progress
Anatomic Pathology Lab Services
I-O clinical development podcast series
Pediatrics Drug Development Solutions
Download our brochure for information about our pediatric sampling capabilities
IQVIA Laboratories Corporate Brochure
A global drug discovery and development laboratory services organization
